Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine tender-point injection for chronic daily headache
IRCT20200305046704N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine in chronic daily headache (CDH) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Average daily headache severity and Number of headache days per week. Started Mar 2020; status: completed.
02
Drugs
lidocaine
03
Conditions
chronic daily headache (CDH)
Beyond the preview
Go deeper on IRCT20200305046704N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200305046704N1.